Cargando…

Influences of Two FEV(1) Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients

OBJECTIVE: To explore the clinical effects of different forced expiratory volume in 1s (FEV(1)) reference equations on chronic obstructive pulmonary disease (COPD) airflow limitation (AFL) classification. METHODS: We conducted a COPD screening program for residents over 40 years old from 2019 to 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Dafei, Wang, Qi, Liu, Shasha, Tan, Xiaowu, Chen, Lin, Tu, Rongfang, Liu, Qing, Jia, Yuanhang, Liu, Sha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447406/ https://www.ncbi.nlm.nih.gov/pubmed/36081764 http://dx.doi.org/10.2147/COPD.S373834

Ejemplares similares

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
por: Heraganahally, Subash S, et al.
Publicado: (2021)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
por: Kirkby, Jane, et al.
Publicado: (2019)

Relationship between FEV1 and Cardiovascular Risk Factors in General Population without Airflow Limitation
por: Lee, Jeong Hyeon, et al.
Publicado: (2016)

Prevalence and characteristics of chronic obstructive pulmonary disease in China with a diagnostic criterion of FEV(1)/FVC less than the lower limit of normal—a reanalysis of Chinese epidemiological survey of COPD (CESCOPD) study
por: Liu, Sha, et al.
Publicado: (2021)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

Comparison between reference values for FVC, FEV(1), and FEV(1)/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2014)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Predictors of accelerated FEV(1) decline in adults with airflow limitation—Findings from the Health2006 cohort
por: Baarnes, Camilla Boslev, et al.
Publicado: (2019)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?
por: Carvalho-Jr, Luiz Carlos S, et al.
Publicado: (2018)

Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a cross-sectional observational study in primary care
por: Sluga, Romina, et al.
Publicado: (2014)

Combination therapy for airflow limitation in COPD
por: Ghanei, Mostafa, et al.
Publicado: (2012)

Not every irreversible airflow obstruction is COPD
por: Baddini-Martinez, José
Publicado: (2016)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV(1)/FVC ratio
por: Berton, Danilo Cortozi, et al.
Publicado: (2019)

GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study
por: Lenoir, Alexandra, et al.
Publicado: (2018)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

The contribution of FEV(1) and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real‐world cohort
por: Satia, Imran, et al.
Publicado: (2020)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Absence of airflow obstruction on spirometry: can it still be COPD?
por: Neder, José Alberto, et al.
Publicado: (2020)

Changes in interpretation of spirometry by implementing the GLI 2012 reference equations: impact on patients tested in a hospital-based PFT lab in a large metropolitan city
por: Kitazawa, Haruna, et al.
Publicado: (2022)

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation
por: Murphy, Daniel E, et al.
Publicado: (2013)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients
por: Song, Qing, et al.
Publicado: (2021)

Estimation of TGF-β1 genotypes in Egyptian smokers; association with FEV(1) in COPD patients
por: Bohy, Mohammad El, et al.
Publicado: (2010)

A novel CT-emphysema index/FEV(1) approach of phenotyping COPD to predict mortality
por: Loh, Li-Cher, et al.
Publicado: (2018)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3po23n2h51eqqvmkf8l37s1jd1